Drugs / AN2898
last change Nov 2011 re-read 2 minutes ago

AN2898

Developed for
atopic eczema
Investigated by
Pfizer

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01301508 May → Nov 2011 atopic eczema Pfizer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AN2898 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01301508
Route Topical Topically Applied AN2898 and AN2728” NCT01301508